In addition, at the cellular level, there was impaired AnxA1 production in CD4+CD252 conventional T and CD4+RORgt+ T (Th17) cells from RRMS subjects that were associated with an increased migratory capacity in an in vitro BBB model. Here, CD4 is linked to relapsing-remitting multiple sclerosis.